06 October 2023
The Jersey Immunisation Report 2022-2023 has been published. The report covers:
- Vaccinations offered to all children up to the age of 5 years, derived from the Cover of Vaccination Evaluated Rapidly (COVER) surveillance scheme
- Uptake of adolescent vaccines offered to young people in school years 8 and 9
- Vaccine preventable disease that are more common with age, as immune systems may not respond as well as we get older, including:
- shingles
- pneumococcal disease
- Vaccines recommended in pregnancy – pertussis (whooping cough)
The data for this report is taken from the Child Health Information System and primary care (GPs). The report shows that:
- In 2022 vaccination coverage for childhood immunisations in Jersey was still relatively high compared to other countries. Jersey has met, or been near the target of 95% coverage for all age groups
- In 2022-2023 the rate of teenagers in Jersey receiving their recommended vaccines has declined, since the pandemic. Many countries have also seen a similar decrease in vaccination coverage
- Adult immunisation can be associated with improved health and quality of life, in some cases reducing the risk of hospitalisation and death. Despite this, vaccination rates for adults are almost always lower than in paediatric populations
- There was encouraging coverage early in the shingles vaccination programme. However, coverage has varied and has remained fairly similar since the start of the programme
- Across Europe, vaccination against pneumococcal disease remains low. However, pneumococcal vaccination coverage for adults aged 65 years in Jersey has gradually increased over the past six years
- Pertussis vaccination coverage for pregnant women in Jersey has remained at similar levels for the past six years.